Encompass Health Corp·4

Feb 12, 3:40 PM ET

Tarr Mark J 4

Research Summary

AI-generated summary

Updated

Encompass Health (EHC) CEO Mark J. Tarr Sells 150,000 Shares

What Happened
Mark J. Tarr, President & CEO and a director of Encompass Health Corporation (EHC), sold a total of 150,000 common shares in open-market transactions on February 11, 2026. The trades were reported on an SEC Form 4 filed February 12, 2026. The sales were executed in multiple lots at weighted-average prices and individual prices ranging roughly from $107.47 up to $113.58, generating aggregate proceeds of approximately $16,746,689.

Key Details

  • Transaction date: February 11, 2026; Form 4 filed February 12, 2026 (timely filing).
  • Individual lots reported:
    • 16,216 shares at $108.03 (F1; weighted avg; prices in range $107.47–$108.45) — $1,751,814
    • 13,231 shares at $108.80 (F2; weighted avg; $108.47–$109.17) — $1,439,533
    • 15,584 shares at $110.07 (F3; weighted avg; $109.52–$110.51) — $1,715,331
    • 10,954 shares at $110.92 (F4; weighted avg; $110.52–$111.51) — $1,215,018
    • 6,057 shares at $111.89 (F5; weighted avg; $111.55–$112.53) — $677,718
    • 87,745 shares at $113.09 (F6; weighted avg; $112.58–$113.52) — $9,923,082
    • 213 shares at $113.58 (single-price lot) — $24,193
  • Total: 150,000 shares sold for about $16,746,689.
  • Footnotes F1–F6 indicate the reported per-share prices are weighted averages across multiple trades; the filing says full per-price breakdowns will be provided upon request.
  • Shares owned after the transactions are not included in the details you provided — see the full Form 4 filing for post-transaction holdings.
  • No indication in the provided data of a 10b5-1 plan, gift, option exercise, or tax-withholding disposition; this was an open-market sale.

Context
These were sales (disposals), which are common for executives for reasons such as diversification, tax planning, or liquidity needs; sales do not necessarily indicate negative views about the company. Purchases typically carry more direct bullish signal than routine sales. Retail investors who want the exact post-transaction holdings or the per-trade price breakdowns should review the full SEC Form 4 (accession 0000785161-26-000032) or request the detailed breakdown referenced in the footnotes.